Please provide your email address to receive an email when new articles are posted on . A pulmonary artery sensor for patients with heart failure beat performance goals related to clinical outcomes.
Please provide your email address to receive an email when new articles are posted on . The FDA granted premarket approval to Endotronix’s pulmonary artery sensor platform for remote management of ...
Guideline-directed medical therapy (GDMT) is used to treat patients with heart failure (HF) with reduced ejection fraction (HFrEF), although optimal dosing and titration of medications remain ...
The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RE(TM) initiative to engage key U.S. healthcare ...
Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, ...
Details of the TN-201 clinical data presentation are as follows: ...
Heart failure affects approximately 6.2 million Americans, with numbers projected to rise as the population ages. Despite its ominous name, heart failure does not mean the heart has stopped ...
Julie Manas is all about patients.Whether it was as president of Genesis Medical Center in Davenport, Iowa, where she led a patient-first/patient safety initiative that brought the hospital national ...
The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback